Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants

We identified neutralizing monoclonal antibodies against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants (including Omicron variants BA.5 and BA.2.75) from individuals who received two doses of mRNA vaccination after they had been infected with the D614G virus. We named them MO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishimaru, Hanako, Nishimura, Mitsuhiro, Tjan, Lidya Handayani, Sutandhio, Silvia, Marini, Maria Istiqomah, Effendi, Gema Barlian, Shigematsu, Hideki, Kato, Koji, Hasegawa, Natsumi, Aoki, Kaito, Kurahashi, Yukiya, Furukawa, Koichi, Shinohara, Mai, Nakamura, Tomoka, Arii, Jun, Nagano, Tatsuya, Nakamura, Sachiko, Sano, Shigeru, Iwata, Sachiyo, Okamura, Shinya, Mori, Yasuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308935/
https://www.ncbi.nlm.nih.gov/pubmed/37191569
http://dx.doi.org/10.1128/jvi.00286-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308935/
https://www.ncbi.nlm.nih.gov/pubmed/37191569
http://dx.doi.org/10.1128/jvi.00286-23

Ejemplares similares